Article Information
History
- July 30, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Mary Chesshyre1,3,
- Deborah Ridout2,3,
- Yasumasa Hashimoto4,
- Yoko Ookubo4,
- Silvia Torelli1,
- Kate Maresh1,3,
- Valeria Ricotti1,3,
- Lianne Abbott1,3,
- Vandana Ayyar Gupta1,
- Marion Main1,3,
- Mariacristina Scoto1,3,
- Giovanni Baranello1,3,
- Adnan Manzur1,3,
- Yoshitsugu Aoki4,
- Francesco Muntoni1,3,* and
- On behalf of the North Star clinical network
- 1Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N EH, United Kingdom
- 2Population, Policy and Practice Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, United Kingdom
- 3NIHR Great Ormond Street Hospital Biomedical Research Centre, UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, United Kingdom
- 4Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo 187-8502, Japan
- ↵*Corresponding author Professor Francesco Muntoni, Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, United Kingdom, f.muntoni{at}ucl.ac.uk
Posted July 30, 2021.
Duchenne muscular dystrophy patients lacking the dystrophin isoforms Dp140 and Dp71 and mouse models lacking Dp140 have a more severe motor phenotype
